Business thrives on unproven care, leaving science behind: a special report.
D000328:Adult; D001853:Bone Marrow; D001943:Breast Neoplasms; D002648:Child; D004467:Economics; D035082:Federal Government; D005260:Female; D006076:Government; D033161:Government Regulation; D006269:Health Facilities, Proprietary; D006761:Hospitals; D006805:Human Experimentation; D006801:Humans; D007221:Industry; D007349:Insurance, Health, Reimbursement; D009369:Neoplasms; D018579:Patient Selection; D010820:Physicians; D011897:Random Allocation; D012106:Research; D035842:Research Subjects; D012926:Social Control, Formal; D012927:Social Control, Informal; D036302:Therapeutic Human Experimentation; D016378:Tissue Transplantation; D016896:Treatment Outcome; D014481:United States; D014930:Women
Biomedical and Behavioral Research; Health Care and Public Health; Popular Approach/Source